Published in Medical Letter on the CDC and FDA, May 15th, 2005
Under the agreement terms, Prisma will conduct a clinical trial in Rome, Italy using the ComfortScan system to show the quality of the system and obtain local acceptance and registration specific to their respective countries, Italy, Portugal, and Bulgaria.
With the addition of Prisma, the DOBI Medical global distribution network now includes 10 international distributors covering 4 continents. International countries include: India, Russia, Canada, Brazil, Panama,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.